Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

HIV Infection

Free Subscription 18.10.2021 11 AIDS 1 Ann Intern Med 1 Antimicrob Agents Chemother 5 Clin Infect Dis 8 HIV Med 2 Int J Cancer 6 J Acquir Immune Defic Syndr 1 J Immunol 2 J Med Virol 2 J Virol 1 Nat Rev Immunol 6 PLoS One 1 PLoS Pathog 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AIDS

1. NICHOLS BE, Rosen S
   Economic evaluations of differentiated service delivery should include savings and ancillary benefits, not only health system costs: authors' reply.
   AIDS. 2021;35:2235-2236.
   PubMed        
   
   
2. SILVEIRA ELV, Hong JJ, Amancha PK, Rogers KA, et al
   Viremia controls Env-specific antibody-secreting cell responses in simian immunodeficiency virus infected macaques pre and post-antiretroviral therapy.
   AIDS. 2021;35:2085-2094.
   PubMed         Abstract available
   
   
3. CACHAY ER, Hadigan C, Mathews WC
   Clinical guidelines for screening of liver cirrhosis complications remain, and clinical judgement must prevail.
   AIDS. 2021;35:2211-2213.
   PubMed        
   
   
4. GENER AR
   Editorial commentary on 'the other side of screening: predictors of treatment and follow-up for anal precancers in a large health system'.
   AIDS. 2021;35:2215-2216.
   PubMed        
   
   
5. HEIL EL, Pandit NS, Taylor GH
   Probable hepatotoxicity from two second-generation integrase strand transfer inhibitors.
   AIDS. 2021;35:2232-2233.
   PubMed        
   
   
6. CLAASSEN CW, Lindsay B, Riedel DJ, Kafunda I, et al
   Economic evaluations of differentiated service delivery should include savings and ancillary benefits, not only health system costs.
   AIDS. 2021;35:2234-2235.
   PubMed        
   
   
7. OLUNIYI PE, Ajogbasile FV, Zhou S, Fred-Akintunwa I, et al
   HIV-1 drug resistance and genetic diversity in a cohort of people living with HIV-1 in Nigeria.
   AIDS. 2021 Oct 7. pii: 00002030-900000000-96299.
   PubMed         Abstract available
   
   
8. EASTMENT MC, Wanje G, Richardson BA, Mwaringa E, et al
   Results of a cluster randomized trial testing the systems analysis and improvement approach to increase HIV testing in family planning clinics in Mombasa, Kenya.
   AIDS. 2021 Oct 8. pii: 00002030-900000000-96295.
   PubMed         Abstract available
   
   
9. SIDDIQUI J, Samuel SK, Hayward B, Wirka KA, et al
   HIV-associated wasting prevalence in the era of modern antiretroviral therapy: a claims database study (2012-2018).
   AIDS. 2021 Oct 12. pii: 00002030-900000000-96296.
   PubMed         Abstract available
   
   
10. YAN H, Peters H, Thorne C
    Neonatal deaths among infants born to women living with HIV in the UK and Ireland 1998-2017.
    AIDS. 2021 Oct 7. pii: 00002030-900000000-96297.
    PubMed         Abstract available
    
    
11. RONALD R, Gartland M, Li Z, Zhou N, et al
    Clinical evidence for a lack of cross-resistance between temsavir and ibalizumab or maraviroc.
    AIDS. 2021 Oct 7. pii: 00002030-900000000-96298.
    PubMed         Abstract available
    
    

    
    Ann Intern Med

12. DOMBROWSKI JC
    Chlamydia and Gonorrhea.
    Ann Intern Med. 2021 Oct 12. doi: 10.7326/AITC202110190.
    PubMed         Abstract available
    
    

    
    Antimicrob Agents Chemother

13. DEKKER JG, Klaver B, Berkhout B, Das AT, et al
    Mutations in the HIV-1 3'-polypurine tract can confer dolutegravir resistance.
    Antimicrob Agents Chemother. 2021 Oct 11:AAC0102721. doi: 10.1128/AAC.01027.
    PubMed         Abstract available
    
    

    
    Clin Infect Dis

14. HUANG J, Xie N, Hu X, Yan H, et al
    Epidemiological, virological and serological features of COVID-19 cases in people living with HIV in Wuhan City: A population-based cohort study.
    Clin Infect Dis. 2020 Aug 17. pii: 5893115. doi: 10.1093/cid/ciaa1186.
    PubMed         Abstract available
    
    
15. BOULLE A, Davies MA, Hussey H, Ismail M, et al
    Risk factors for COVID-19 death in a population cohort study from the Western Cape Province, South Africa.
    Clin Infect Dis. 2020 Aug 29. pii: 5899044. doi: 10.1093/cid/ciaa1198.
    PubMed         Abstract available
    
    
16. VENTER WDF, Nel J
    COVID-19: First data from Africa.
    Clin Infect Dis. 2020 Aug 31. pii: 5899682. doi: 10.1093/cid/ciaa1293.
    PubMed        
    
    
17. DANDACHI D, Geiger G, Montgomery MW, Karmen-Tuohy S, et al
    Characteristics, Comorbidities, and Outcomes in a Multicenter Registry of Patients with HIV and Coronavirus Disease-19.
    Clin Infect Dis. 2020 Sep 9. pii: 5903368. doi: 10.1093/cid/ciaa1339.
    PubMed         Abstract available
    
    
18. HENDERSON HI, Napravnik S, Gower EW, Aiello AE, et al
    Resistance in Enterobacterales is higher among people with HIV.
    Clin Infect Dis. 2021 Oct 13. pii: 6395207. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    HIV Med

19. VASCONCELOS R, Avelino-Silva VI, de Paula IA, Jamal LF, et al
    HIV self-test: a tool to expand test uptake among men who have sex with men who have never been tested for HIV in Sao Paulo, Brazil.
    HIV Med. 2021 Oct 11. doi: 10.1111/hiv.13178.
    PubMed         Abstract available
    
    
20. NITPOLPRASERT C, Anand T, Phanuphak N, Reiss P, et al
    A qualitative study of the impact of coronavirus disease (COVID-19) on psychological and financial wellbeing and engagement in care among men who have sex with men living with HIV in Thailand.
    HIV Med. 2021 Oct 11. doi: 10.1111/hiv.13190.
    PubMed         Abstract available
    
    
21. JONES TPW, Lampe FC, Arenas-Pinto A, Smith C, et al
    Alcohol, smoking, recreational drug use and association with virological outcomes among people living with HIV: cross-sectional and longitudinal analyses.
    HIV Med. 2021 Oct 11. doi: 10.1111/hiv.13156.
    PubMed         Abstract available
    
    
22. BURNS JE, Stirrup O, Waters L, Dunn D, et al
    No overall impact on rate of weight gain with integrase inhibitor-containing regimens in antiretroviral-naive adults.
    HIV Med. 2021 Oct 11. doi: 10.1111/hiv.13186.
    PubMed         Abstract available
    
    
23. TUAN JJ, Zapata H, Critch-Gilfillan T, Ryall L, et al
    Qualitative assessment of anti-SARS-CoV-2 spike protein immunogenicity (QUASI) after COVID-19 vaccination in older people living with HIV.
    HIV Med. 2021 Oct 10. doi: 10.1111/hiv.13188.
    PubMed         Abstract available
    
    
24. RICK F, Odoke W, van den Hombergh J, Benzaken AS, et al
    Impact of coronavirus disease (COVID-19) on HIV testing and care provision across four continents.
    HIV Med. 2021 Oct 10. doi: 10.1111/hiv.13180.
    PubMed         Abstract available
    
    
25. BROWN JA, Nsakala BL, Mokhele K, Rakuoane I, et al
    Viral suppression after transition from nonnucleoside reverse transcriptase inhibitor- to dolutegravir-based antiretroviral therapy: A prospective cohort study in Lesotho (DO-REAL study).
    HIV Med. 2021 Oct 10. doi: 10.1111/hiv.13189.
    PubMed         Abstract available
    
    
26. SILVERSTEIN A, Kamiyango W, Villiera J, Peckham-Gregory EC, et al
    Long-term outcomes for children and adolescents with Kaposi sarcoma.
    HIV Med. 2021 Oct 11. doi: 10.1111/hiv.13191.
    PubMed         Abstract available
    
    

    
    Int J Cancer

27. MPUNGA T, Clifford GM, Morgan EA, Milner DA Jr, et al
    Epstein-Barr virus prevalence among subtypes of malignant lymphoma in Rwanda, 2012-2018.
    Int J Cancer. 2021 Oct 9. doi: 10.1002/ijc.33840.
    PubMed         Abstract available
    
    
28. IBRAHIM KHALIL A, Mpunga T, Wei F, Baussano I, et al
    Age-specific burden of cervical cancer associated with HIV: a global analysis with a focus on sub-Saharan Africa.
    Int J Cancer. 2021 Oct 9. doi: 10.1002/ijc.33841.
    PubMed         Abstract available
    
    

    
    J Acquir Immune Defic Syndr

29. LONGINO AA, Paul R, Wang Y, Lama JR, et al
    HIV disease dynamics, markers of inflammation and CNS injury during primary HIV infection and their relationship to cognitive performance.
    J Acquir Immune Defic Syndr. 2021 Oct 7. pii: 00126334-900000000-95788.
    PubMed         Abstract available
    
    
30. PYRA M, Brewer R, Rusie L, Kline J, et al
    Long-term HIV Pre-exposure Prophylaxis Trajectories Among Racial & Ethnic Minority Patients: Short, Declining, & Sustained Adherence.
    J Acquir Immune Defic Syndr. 2021 Oct 9. pii: 00126334-900000000-95782.
    PubMed         Abstract available
    
    
31. KAPLAN SR, Escudero JN, Mecha J, Richardson BA, et al
    Interferon gamma release-assay and tuberculin skin test performance in pregnant women living with and without HIV.
    J Acquir Immune Defic Syndr. 2021 Oct 6. pii: 00126334-900000000-95787.
    PubMed         Abstract available
    
    
32. DIAZ RS, Grangeiro A, Estevam DL, Galinskas J, et al
    Pre-exposure prophylaxis failure with a multiple drug-resistant HIV-1 clade C virus in Brazil.
    J Acquir Immune Defic Syndr. 2021 Oct 6. pii: 00126334-900000000-95786.
    PubMed        
    
    
33. HELLER T, Wallrauch C, Gumulira J, Rambiki K, et al
    Low CD4 counts despite effective ART in hospitalized Malawian HIV+/COVID+ co-infected patients.
    J Acquir Immune Defic Syndr. 2021 Oct 6. pii: 00126334-900000000-95783.
    PubMed        
    
    
34. FAZELI PL, Woods SP, Lambert CC, Li W, et al
    Differential Associations Between BDNF and Memory Across Older Black and White Adults with HIV Disease.
    J Acquir Immune Defic Syndr. 2021 Oct 6. pii: 00126334-900000000-95784.
    PubMed         Abstract available
    
    

    
    J Immunol

35. PAIDI RK, Jana M, Mishra RK, Dutta D, et al
    Selective Inhibition of the Interaction between SARS-CoV-2 Spike S1 and ACE2 by SPIDAR Peptide Induces Anti-Inflammatory Therapeutic Responses.
    J Immunol. 2021 Oct 13. pii: jimmunol.2100144. doi: 10.4049/jimmunol.2100144.
    PubMed         Abstract available
    
    

    
    J Med Virol

36. MATSUDA EM, Ahagon CM, Coelho LPO, Campos IB, et al
    A simple algorithm for selecting cases to investigate acute and early HIV infections in low- and middle-income countries.
    J Med Virol. 2021 Oct 14. doi: 10.1002/jmv.27398.
    PubMed         Abstract available
    
    
37. RAHMAN S, Sarker MS, Aralaguppe SG, Sarwar G, et al
    Drug resistance pattern among ART-naive clients attending an HIV testing and counseling center in Dhaka, Bangladesh.
    J Med Virol. 2021 Oct 12. doi: 10.1002/jmv.27387.
    PubMed         Abstract available
    
    

    
    J Virol

38. BALAMURUGAN A, Ng HL, Yang OO
    Correction for Balamurugan et al., "Cross-Reactivity against Multiple HIV-1 Epitopes Is Characteristic of HIV-1-Specific Cytotoxic T Lymphocyte Clones".
    J Virol. 2021;95:e0139721.
    PubMed        
    
    
39. BENNER BE, Bruce JW, Kentala JR, Murray M, et al
    Perturbing HIV-1 ribosomal frameshifting frequency reveals a cis preference for Gag-Pol incorporation into assembling virions.
    J Virol. 2021 Oct 13:JVI0134921. doi: 10.1128/JVI.01349.
    PubMed         Abstract available
    
    

    
    Nat Rev Immunol

40. MAJDOUL S, Compton AA
    Lessons in self-defence: inhibition of virus entry by intrinsic immunity.
    Nat Rev Immunol. 2021 Oct 13. pii: 10.1038/s41577-021-00626.
    PubMed         Abstract available
    
    

    
    PLoS One

41. FOCA E, Calcagno A, Calza S, Renzetti S, et al
    Durability of Integrase STrand Inhibitor (InSTI)-based regimen in geriatric people living with HIV in the GEPPO cohort.
    PLoS One. 2021;16:e0258533.
    PubMed         Abstract available
    
    
42. 
    Correction: Use of fourth-generation rapid combined antigen and antibody diagnostic tests for the detection of acute HIV infection in a community centre for men who have sex with men, between 2016 and 2019.
    PLoS One. 2021;16:e0258613.
    PubMed         Abstract available
    
    
43. ELKARANSHAWY HA, Ezzat HM, Ibrahim NN
    Lyapunov function and global asymptotic stability for a new multiscale viral dynamics model incorporating the immune system response: Implemented upon HCV.
    PLoS One. 2021;16:e0257975.
    PubMed         Abstract available
    
    
44. TEKLIYE E, Alemayehu T, Bacha T
    Clinical, immunologic and virologic outcomes of children and adolescents receiving second line anti-retroviral therapy in two referral hospitals in Addis Ababa, Ethiopia.
    PLoS One. 2021;16:e0249085.
    PubMed         Abstract available
    
    
45. ROUSSEAU E, Katz AWK, O'Rourke S, Bekker LG, et al
    Adolescent girls and young women's PrEP-user journey during an implementation science study in South Africa and Kenya.
    PLoS One. 2021;16:e0258542.
    PubMed         Abstract available
    
    
46. NGUYEN QT, Ishizaki A, Bi X, Matsuda K, et al
    Alterations in children's sub-dominant gut microbiota by HIV infection and anti-retroviral therapy.
    PLoS One. 2021;16:e0258226.
    PubMed         Abstract available
    
    

    
    PLoS Pathog

47. BOCHART RM, Busman-Sahay K, Bondoc S, Morrow DW, et al
    Mitigation of endemic GI-tract pathogen-mediated inflammation through development of multimodal treatment regimen and its impact on SIV acquisition in rhesus macaques.
    PLoS Pathog. 2021;17:e1009565.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

48. RAK R, Polonsky M, Eizenberg-Magar I, Mo Y, et al
    Dynamic changes in tRNA modifications and abundance during T cell activation.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: